Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

NPPA Fixes Retail Price Of 3 Formulations; Details

Farhat Nasim13 Jun 2020 10:30 AM IST

These include some popular combination drugs namely Vildagliptin + Metformin Tablet manufactured by Morepen Laboratories Ltd; Escitalopram +...

Ascent backed-Naari buys 10 ANDAs from Intas Pharma

Farhat Nasim12 Jun 2020 3:07 PM IST

The portfolio acquired comprises eight U.S. FDA approved ANDAs and two products pending approval. It includes generic products in female hormones...

SRL lab asked to pay Rs 99 lakh compensation for allegedly wrongly diagnosing lawyer with COVID

Farhat Nasim12 Jun 2020 2:28 PM IST

Mumbai: Blaming the private laboratory for providing an incorrect COVID positive report, a city-based lawyer has sent a legal notice to SRL...

Gandhi Hospital: Two Attendants of COVID victim held for assaulting junior doctor with iron stand

Farhat Nasim11 Jun 2020 6:04 PM IST

The incident triggered protests by doctors who demanded additional security to prevent such incidents and deployment of special protection force at...

Drug Alert: CDSCO Flags 25 Drugs As Not Of Standard Quality

Farhat Nasim11 Jun 2020 1:53 PM IST

This came after analysis and test conducted by the CDSCO, Drugs Control Departments, on 477 drug samples. Out of this, 452 samples were found of...

Rs 500 Crore Medanta Hospital to Transform Healthcare in Assam

Medanta Hospital refutes land grabbing allegations, calls petitioner "Extortionist"

Farhat Nasim11 Jun 2020 1:44 PM IST

Raman Sharma has been accused of extortion in 2015 and an FIR was registered against him (FIR 0548 dated 10/10/2015 at the Central Police Station,...

Corruption Charges: KGMU sacks Pediatric Surgery professor, assistant professor from services, to file FIR

Farhat Nasim11 Jun 2020 11:30 AM IST

Lucknow: Taking cognizance of violation of service rules, a professor of the pediatric surgery department; and an assistant...

COVID-19 Impact: Dr Reddys, Wockhardt alter Rs 1850 crore deal terms

Farhat Nasim11 Jun 2020 11:06 AM IST

Subsequently, through an amendment to the BTA, Dr.Reddys and Wockhardt that 1,483 crore would be paid on the date of closing the deal consideration,...

Panacea Biotec, Refana enter landmark collaboration for COVID-19 Vaccine

Farhat Nasim10 Jun 2020 6:15 PM IST

Collaboration will enable global development, manufacturing and distribution of the Candidate COVID-19 vaccine.

NPPA, Centre Asked To Cap Prices of N95 Masks

Farhat Nasim10 Jun 2020 5:31 PM IST

The reduced MRPs of N95 Masks by NPPA are in fact 450-850% higher than the January (2020) price shelled out by a government body.

Rs 2375 crore Religare Finvest Scam: Delhi HC asks AIIMS Director to constitute medical board to look into treatment of key Accused

Farhat Nasim10 Jun 2020 5:00 PM IST

The counsel submitted that X-ray and ultrasound reports of Kavi Arora have not been provided and his health is deteriorating day-by-day in jail and...

Serum Institute to infuse Rs 755 crore on potential COVID-19 vaccine

Farhat Nasim10 Jun 2020 12:46 PM IST

"Our manufacturing facility is ready and we plan to start production in two months. We are spending more than $100 million for this facility. Till the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok